Imaging Cancer
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Dr Nigel Bennee.
Please note this week the lecture is on Tuesday not Monday
Patients with similar tumour types can have markedly different responses to the same therapy. The development of new treatments would benefit significantly from the introduction of imaging methods that allow an early assessment of treatment response in individual patients, allowing rapid selection of the most effective treatment.
We have been developing non-invasive and clinically applicable magnetic resonance-based methods for detecting the early responses of tumours to therapy. Primarily, these are methods for detecting tumour cell death; the level of tumour cell death following drug treatment is a good predictive indicator for treatment outcome. By monitoring tumour cell death we may get an indication of whether a particular drug is working very early during treatment, possibly within 24-48 hours, and long before there is any evidence of tumour shrinkage
This talk is part of the Cambridge Society for the Application of Research (CSAR) series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|
![[Search]](http://talks.cam.ac.uk/images/search.gif?1209136071)
|![[A-Z Index]](http://talks.cam.ac.uk/images/az.gif?1209136071)
|![[Contact]](http://talks.cam.ac.uk/images/contact.gif?1209136071)
![[University of Cambridge]](http://talks.cam.ac.uk/images/identifier2.gif?1209136071){kind=small}
![[Talks.cam]](http://talks.cam.ac.uk/images/talkslogosmall.gif?1209136071)
Dr Kevin Brindle, Cancer Research Institute/Dept. Biochemistry, University of Cambridge
Tuesday 16 February 2010, 19:30-21:00